Enovis (ENOV) Cash from Investing Activities (2010 - 2026)
Enovis (ENOV) posted quarterly Cash from Investing Activities of -$53.1 million for Q2 2026, up 12.27% year-over-year from -$47.3 million in Q2 2025, and down 308.71% quarter-over-quarter from -$13.0 million in Q4 2025.
Enovis (ENOV) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Cash from Investing Activities for 17 consecutive years, with -$53.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 12.27% year-over-year to -$53.1 million; the TTM figure through Apr 2026 stood at -$171.9 million (up 21.18% YoY), while the FY2025 annual figure was -$179.4 million, up 81.23% from the prior year.
- Cash from Investing Activities fell to -$53.1 million in Q2 2026 per ENOV's latest filing, from -$13.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$13.0 million in Q4 2025 and bottomed at -$797.8 million in Q1 2024.
- Historically, Cash from Investing Activities has averaged -$94.5 million across 5 years, with a median of -$53.1 million in 2026.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities sank 2220.32% — and 2025, when it soared 92.41%.
- Enovis' Cash from Investing Activities stood at -$37.1 million in 2022, then slumped by 60.14% to -$59.4 million in 2023, then grew by 2.51% to -$57.9 million in 2024, then jumped by 77.56% to -$13.0 million in 2025, then plunged by 308.71% to -$53.1 million in 2026.
- Business Quant data shows ENOV's Cash from Investing Activities at -$53.1 million in Q2 2026, -$13.0 million in Q4 2025, and -$56.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Enovis | 1.50 Bn | 1.48 Bn | 359.25 Mn | -45.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -45.01 Mn |
| Jul 3, 2026 | -45.01 Mn |
| Apr 3, 2026 | -53.10 Mn |
| Apr 3, 2026 | -53.10 Mn |
| Dec 31, 2025 | -12.99 Mn |
| Dec 31, 2025 | -12.99 Mn |
| Oct 3, 2025 | -56.06 Mn |
| Oct 3, 2025 | -56.06 Mn |
| Jul 4, 2025 | -49.80 Mn |
| Jul 4, 2025 | -49.80 Mn |
| Apr 4, 2025 | -60.52 Mn |
| Apr 4, 2025 | -60.52 Mn |
| Dec 31, 2024 | -57.88 Mn |
| Dec 31, 2024 | -57.88 Mn |
| Sep 27, 2024 | -58.42 Mn |
| Sep 27, 2024 | -58.42 Mn |
| Jun 28, 2024 | -41.33 Mn |
| Jun 28, 2024 | -41.33 Mn |
| Mar 29, 2024 | -797.84 Mn |
| Mar 29, 2024 | -797.84 Mn |